MedPath

Impact of Partial Capsule Decortication on Device-related Infection in Patients Receiving Cardiac Implantable Electronic Device Replacement

Not Applicable
Active, not recruiting
Conditions
Infections
Pacemaker Complication
Interventions
Procedure: Partial capsule decortication
Registration Number
NCT05390216
Lead Sponsor
Shanghai Zhongshan Hospital
Brief Summary

Increasing number of cardiac implantable electronic devices (CIEDs) have been implanted in the worldwide every year, which is accompanied by the growing number of CIED-related infection, especially in patients with CIED replacement. This multicenter, prospective, single-blinded, randomized controlled trial is to confirm the impact of partial capsule decortication on device-related infection in patients receiving CIED replacement.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
1016
Inclusion Criteria
  • Patient is at least 18 years of age

  • Patient is planned to undergo at least one of the following procedures:

    a) Patient has existing CIED (pacemaker, or CRT-P, or ICD, or CRT-D) and is undergoing pulse generator replacement or upgrade with a new generator. b) Patients planned to have leads added, or extracted and added for upgrades.

  • Patient is willing to sign and date informed consent

Exclusion Criteria
  • History of CIED-related infection
  • Open the pocket for any reason within the last one year
  • Any evidence indicating active infection
  • Requirement of long term vascular access for any reason
  • Expected survival time is less than one year
  • Patients who were pregnant or breastfeeding
  • Participation in another study that may confound the results of this study
  • Patient is unable to comply with scheduled follow up

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Partial capsule decorticationPartial capsule decortication-
Primary Outcome Measures
NameTimeMethod
Rate of major CIED-related infectionWithin the first year after the operation

Infections that resulted in CIED system removal, an invasive CIED procedure (e.g., pocket revision without removal), treatment with long-term antibiotic therapy (if the patient was not a candidate for system removal) with infection recurrence after discontinuation of antibiotic therapy, or death.

Secondary Outcome Measures
NameTimeMethod
Rate of device dysfunctionWithin the first year after the operation

All the dysfunction of the generators and leads (including abnormal changes of pacing threshold, sensing, impedance, etc.).

All-cause mortalityWithin the first year after the operation

Death regardless of the causes.

Rate of all CIED-related infectionWithin the first year after the operation

All infections that related to CIED operation.

Rate of minor CIED-related infectionWithin the first year after the operation

Infections that do not meet the definition criteria of major CIED infection.

Rate of pocket hematomaWithin the first year after the operation

Palpable swelling with fluctuance that extended beyond the device margin but without evidence of infection.

Trial Locations

Locations (1)

180 Fenglin Road

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath